Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

EGX:AXPH Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	307.54	216.68	126.43	117.42	117	170.05
Depreciation & Amortization	37.56	37.56	-	23.18	-	-
Other Operating Activities	-140.86	-64.61	-35.09	52.14	-17.57	-30.25
Operating Cash Flow	204.23	189.62	91.34	192.75	99.42	139.8
Operating Cash Flow Growth	25.94%	107.60%	-52.61%	93.87%	-28.88%	1.44%
Capital Expenditures	-30.13	-62.22	-84.25	-31.85	-119.99	-71.22
Sale of Property, Plant & Equipment	0.05	0.56	1.03	-	0.4	-
Other Investing Activities	21.58	13.33	5.38	5.25	5.97	11.21
Investing Cash Flow	-8.5	-48.33	-77.84	-26.6	-113.62	-60.02
Common Dividends Paid	-165.57	-81.97	-76.94	-64.52	-100.29	-78.08
Financing Cash Flow	-165.57	-81.97	-76.94	-64.52	-100.29	-78.08
Net Cash Flow	30.16	59.33	-63.44	101.63	-114.49	1.7
Free Cash Flow	174.1	127.41	7.09	160.9	-20.57	68.57
Free Cash Flow Growth	103.31%	1696.05%	-95.59%	-	-	-45.02%
Free Cash Flow Margin	7.54%	7.21%	0.48%	14.63%	-1.86%	6.69%
Free Cash Flow Per Share	-	25.48	1.42	32.18	-4.11	11.61
Cash Income Tax Paid	51.65	51.65	46.02	49.3	62.87	44.24
Levered Free Cash Flow	128.94	122.74	-44.18	155.37	-46.87	20.89
Unlevered Free Cash Flow	128.94	122.74	-44.18	155.37	-46.87	20.89
Change in Net Working Capital	127.55	19.78	56.76	-79.95	23.2	46.45

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.